Zou Chen-Yu, Li Qian-Jin, Hu Juan-Juan, Song Yu-Ting, Zhang Qing-Yi, Nie Rong, Li-Ling Jesse, Xie Hui-Qi
Laboratory of Stem Cell and Tissue Engineering, Orthopedic Research Institute, Med-X Center for Materials, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China.
Department of Otolaryngology, Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China.
Mater Today Bio. 2022 Oct 18;17:100468. doi: 10.1016/j.mtbio.2022.100468. eCollection 2022 Dec 15.
Uncontrolled bleeding remains as a leading cause of death in surgical, traumatic, and emergency situations. Management of the hemorrhage and development of hemostatic materials are paramount for patient survival. Owing to their inherent biocompatibility, biodegradability and bioactivity, biopolymers such as polysaccharides and polypeptides have been extensively researched and become a focus for the development of next-generation hemostatic materials. The construction of novel hemostatic materials requires in-depth understanding of the physiological hemostatic process, fundamental hemostatic mechanisms, and the effects of material chemistry/physics. Herein, we have recapitulated the common hemostatic strategies and development status of biopolymer-based hemostatic materials. Furthermore, the hemostatic mechanisms of various molecular structures (components and chemical modifications) are summarized from a microscopic perspective, and the design based on them are introduced. From a macroscopic perspective, the design of various forms of hemostatic materials, e.g., powder, sponge, hydrogel and gauze, is summarized and compared, which may provide an enlightenment for the optimization of hemostat design. It has also highlighted current challenges to the development of biopolymer-based hemostatic materials and proposed future directions in chemistry design, advanced form and clinical application.
在外科手术、创伤和紧急情况下,失控性出血仍然是主要的死亡原因。控制出血和开发止血材料对于患者的生存至关重要。由于多糖和多肽等生物聚合物具有固有的生物相容性、生物降解性和生物活性,它们已得到广泛研究,并成为下一代止血材料开发的重点。新型止血材料的构建需要深入了解生理止血过程、基本止血机制以及材料化学/物理的影响。在此,我们概述了基于生物聚合物的止血材料的常见止血策略和发展现状。此外,从微观角度总结了各种分子结构(成分和化学修饰)的止血机制,并介绍了基于这些机制的设计。从宏观角度总结并比较了各种形式的止血材料(如粉末、海绵、水凝胶和纱布)的设计,这可能为优化止血剂设计提供启示。它还强调了基于生物聚合物的止血材料开发目前面临的挑战,并提出了化学设计、先进形式和临床应用方面的未来方向。